Title: Thrombosis and Cancer
1Thrombosis and Cancer
- Mario DICATO, Garry MAHON
- Hematology-Oncology
- Centre Hospitalier
- L-1210 Luxembourg
- dicato.mario_at_chl.lu garry.mahon_at_cec.eu.int
2ESTIMATED PREVALENCE OF VENOUS THROMBOEMBOLISM
DURING THE COURSE OF COMMON TYPES OF CANCER (Ann.
Rev. Med. 1999)
3CANCER TREATMENS AS RISK FACTORS FOR VTE IN
CANCER PATIENTS
4VIIA Xa
TNF-IL-1
TF
VIIa
Tumor cells
monocytes endothelial cells
thrombin
Platelet aggregation
5VENOUS THROMBOPHILIA
- HEREDITARY Prevalence
- AT III 0,2
- Protein C , S 0,2
- VArg 506 (Leiden) 3 - 8
- Hyperhomocysteinemia ( arterial, folic acid),
MTHFR 40 (35-60) - PT
0-2 - ? Plasminogen, Dysfibrinogenemia...
6(No Transcript)
7V Leiden
- Prevalence
- Heterozygotes (Caucasians) 5
- Patient Cohorts DVT 20 - 60
- DVT - Pregnancy 60
- DVT - Oral Birth Control Meds 34
- ! Multiple Genetic Deficits
- Long term studies
- heterozygotes ?
- Ø arterial thrombosis
8V LEIDEN, OESTROGENS AND DVT
- VL OESTROGENS DVT (per 10.000 y)
-
- - - 0,8
- - 3
- - 5,7
- 28,5
- HOMOZYGOSITY 100
- (BMJ 1996, 313 1127)
9ACQUIRED
- ANTIPHOSPHOLIPID Ab
- CANCER
- PNH
- MYELOPROLIFERATIVE SYNDROMES
- NEPHROTIC SYNDROMES
- CHEMOTHERAPY
10V LEIDEN
- Normal population controls 240
- Heterozygotes 18
- Homozygotes 0
- Allele frequency 3,75
- Essential thrombocytemia 41
- Heterozygotes 3
- Homozygotes 0
- Allele frequency 3,65
- M.
Dicato et al. ASH 1998abstr.
11ESSENTIAL THROMBOCYTHEMIA
- n 41
- V Leiden allele frequency 3,65
- PT MTHFR (0 40)
- n 30
- 15 TED
- 8 BLEEDING
- 10 no hemostatic problem
-
- (M.Dicato et al.
ASH 1999, abstr.1119)
12MUTATIONS V LEIDEN, MTHFR AND PT IN CANCER
PATIENTS WITH VENOUS THROMBO-EMBOLIC DISORDERS.
13The Thrombophilic mutations V Leiden, PT and
MTHFR are in Hardy-Weinberg equilibrium
(ASH 2001, M.D. et al. abstr. 3985)
14PATIENTS
- Cancer VTE 54
- Cancer - VTE 53
15FREQUENCY OF MUTATIONS
16CONCLUSION
- In cancer patients with VTE, testing for
- mutations is only useful if there is a
- previous personal or family history
- of VTE
(M. Dicato et al. ASH 2001, Abstr. 3984)